[PDF][PDF] Guidelines for the diagnosis, prevention and management of osteoporosis
…, G Osella, M Pedrazzoni, L Sinigaglia, O Viapiana… - …, 2016 - research.unipd.it
On behalf of the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS)
with the endorsement of Italian Society of Endocrinology (SIE) Italian Society of …
with the endorsement of Italian Society of Endocrinology (SIE) Italian Society of …
Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study
…, V Braga, M Rossini, L Tatò, O Viapiana… - Journal of Bone and …, 2005 - academic.oup.com
In a randomized controlled study, we investigated the effect of treatment with intravenous
neridronate in prepubertal children with OI. Our study suggests that quarterly intravenous …
neridronate in prepubertal children with OI. Our study suggests that quarterly intravenous …
The obesity paradox and osteoporosis
Overweight and obesity according to the definition of the WHO are considered as an
abnormal or excessive fat accumulation that may impair health. Studies comparing fracture …
abnormal or excessive fat accumulation that may impair health. Studies comparing fracture …
Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake
Vitamin D deficiency is extremely common among elderly subjects and it has been
associated with poor bone health, and to a number of other conditions. The ideal 25-hydroxy-vitamin …
associated with poor bone health, and to a number of other conditions. The ideal 25-hydroxy-vitamin …
[HTML][HTML] Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial
…, I Prevete, L Sinigaglia, M Valenti, O Viapiana… - PLoS …, 2019 - journals.plos.org
Background The inflammatory contribution to type 2 diabetes (T2D) has suggested new
therapeutic targets using biologic drugs designed for rheumatoid arthritis (RA). On this basis, we …
therapeutic targets using biologic drugs designed for rheumatoid arthritis (RA). On this basis, we …
[HTML][HTML] Osteoporosis in rheumatic diseases
…, C Caimmi, A Giollo, G Orsolini, O Viapiana… - International journal of …, 2019 - mdpi.com
Osteoporosis is a chronic disease characterized by an increased risk of fragility fracture.
Patients affected by rheumatic diseases are at greater risk of developing osteoporosis. The …
Patients affected by rheumatic diseases are at greater risk of developing osteoporosis. The …
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis
…, D Schena, D Vecchiato, M Bonifacio, O Viapiana… - Bone, 2011 - Elsevier
OBJECTIVE: We systematically assessed bone mineral density (BMD), bone turnover markers
(BTM), and fractures in a large cohort of patients with Indolent Systemic Mastocytosis (ISM)…
(BTM), and fractures in a large cohort of patients with Indolent Systemic Mastocytosis (ISM)…
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study
Growing data have provided encouraging results on the use of interleukin (IL)-1 inhibitors in
Behçet’s disease (BD). This study was aimed at reporting the largest experience with anti-IL-…
Behçet’s disease (BD). This study was aimed at reporting the largest experience with anti-IL-…
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis
Patients living with osteoporosis are projected to increase dramatically in the next decade.
Alongside the forecasted increased societal and economic burden, we will live a crisis of …
Alongside the forecasted increased societal and economic burden, we will live a crisis of …
Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab
D Gatti, O Viapiana, E Fracassi… - Journal of Bone and …, 2012 - academic.oup.com
The bone mass benefits of antiresorbers in postmenopausal osteoporosis are limited by the
rapid coupling of decreasing bone resorption with bone formation. Wnt signaling is involved …
rapid coupling of decreasing bone resorption with bone formation. Wnt signaling is involved …